Cargando…
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
The Ki-67 antigen is used to evaluate the proliferative activity of breast cancer (BC); however, Ki-67's role as a prognostic marker in BC is still undefined. In order to better define the prognostic value of Ki-67/MIB-1, we performed a meta-analysis of studies that evaluated the impact of Ki-6...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359936/ https://www.ncbi.nlm.nih.gov/pubmed/17453008 http://dx.doi.org/10.1038/sj.bjc.6603756 |